...
机译:靶向乳腺肿瘤的抗人类内源性逆转录病毒-K包膜蛋白抗体的免疫治疗潜力
Department of Veterinary Sciences Michale E. Keeling Center for Comparative Medicine and Research;
Department of Veterinary Sciences Michale E. Keeling Center for Comparative Medicine and Research;
Department of Veterinary Sciences Michale E. Keeling Center for Comparative Medicine and Research;
Department of Veterinary Sciences Michale E. Keeling Center for Comparative Medicine and Research;
Department of Veterinary Sciences Michale E. Keeling Center for Comparative Medicine and Research;
Department of Veterinary Sciences Michale E. Keeling Center for Comparative Medicine and Research;
Department of Veterinary Sciences Michale E. Keeling Center for Comparative Medicine and Research;
Department of Carcinogenesis MD Anderson Cancer Center Houston TX United States;
Department of Carcinogenesis MD Anderson Cancer Center Houston TX United States;
Department of Pathology and Laboratory Medicine University of Texas Health Science Center at;
Laboratory of Human Carcinogenesis National Cancer Institute Bethesda MD United States;
Laboratory of Human Carcinogenesis National Cancer Institute Bethesda MD United States;
Department of Surgical Oncology MD Anderson Cancer Center Houston TX United States;
Laboratory of Human Carcinogenesis National Cancer Institute Bethesda MD United States;
University of Texas MD Anderson Cancer Center Houston TX United States Michale E. Keeling;
机译:抗人类内源性逆转录病毒-K包膜蛋白抗体在靶向乳腺癌中的免疫治疗潜力。
机译:抗人内源性逆转录病毒-k包膜蛋白抗体在靶向乳腺肿瘤中的免疫治疗潜力
机译:靶向乳腺肿瘤的抗人类内源性逆转录病毒-K包膜蛋白抗体的免疫治疗潜力
机译:具有新型单链4-1BBL或OX40L抗体融合蛋白的靶向共刺激促进了肿瘤指导的T细胞活化
机译:针对HER2 / neu或肿瘤相关糖蛋白-72的单克隆抗体的Fab片段,用于乳腺癌的放射免疫检测
机译:抗人类内源性逆转录病毒-K包膜蛋白抗体在靶向乳腺癌中的免疫治疗潜力。
机译:肝脏母细胞瘤中的人内源性逆转录病毒-K(HML-2)MRNA的上调:鉴定潜在的新免疫治疗靶标和生物标志物